Quantum Genomics (STU:2QG) Interest Expense : €-0.02 Mil (TTM As of Dec. 2022)

View and export this data going back to 2018. Start your Free Trial

What is Quantum Genomics Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Quantum Genomics's interest expense for the six months ended in Dec. 2022 was € 0.01 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2022 was €-0.02 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Quantum Genomics's Operating Income for the six months ended in Dec. 2022 was € -18.33 Mil. Quantum Genomics's Interest Expense for the six months ended in Dec. 2022 was € 0.01 Mil. Quantum Genomics did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Quantum Genomics Interest Expense Historical Data

The historical data trend for Quantum Genomics's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Quantum Genomics Interest Expense Chart

Quantum Genomics Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Interest Expense

Get a 7-Day Free Trial

-0.01

-0.02

Quantum Genomics Semi-Annual Data
	Jun13	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22
Interest Expense	Get a 7-Day Free Trial															-0.01	-0.01	-	-0.03	0.01

Quantum Genomics Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2022 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-0.02 Mil.

Quantum Genomics (STU:2QG) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Quantum Genomics's Interest Expense for the six months ended in Dec. 2022 was €0.01 Mil. Its Operating Income for the six months ended in Dec. 2022 was €-18.33 Mil. And its Long-Term Debt & Capital Lease Obligation for the six months ended in Dec. 2022 was €3.03 Mil.

Quantum Genomics's Interest Coverage for the quarter that ended in Dec. 2022 is calculated as

The higher the ratio, the stronger the company's financial strength is.

Quantum Genomics (STU:2QG) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Quantum Genomics (STU:2QG) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

33, Rue Marbeuf, Paris, FRA, 75008

Website

https://quantum-genomics.com

Quantum Genomics is a biopharmaceutical company engaged in developing new products for unmet needs in the field of cardiovascular diseases, high blood pressure, and heart failure. The company products include firibastat, QGC006, QGC011, and others.

Quantum Genomics (STU:2QG) Headlines

No Headlines